2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
Titel:
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
Auteur:
Mancini, G.B. John O’Meara, Eileen Zieroth, Shelley Bernier, Mathieu Cheng, Alice Y.Y. Cherney, David Z.I. Connelly, Kim A. Ezekowitz, Justin Goldenberg, Ronald M. Leiter, Lawrence A. Nesrallah, Gihad Paty, Breay W. Piché, Marie-Eve Senior, Peter Sharma, Abhinav Verma, Subodh Woo, Vincent Darras, Pol Gabor, Jonathan Y. Grégoire, Jean Lonn, Eva Stone, James A. Yale, Jean-François Yeung, Colin Zimmerman, Deborah